000901792 001__ 901792
000901792 005__ 20211025171516.0
000901792 0247_ $$2doi$$a10.1093/neuonc/noab098
000901792 0247_ $$2ISSN$$a1522-8517
000901792 0247_ $$2ISSN$$a1523-5866
000901792 0247_ $$2pmid$$a34081114
000901792 0247_ $$2WOS$$aWOS:000685248000026
000901792 037__ $$aFZJ-2021-03825
000901792 082__ $$a610
000901792 1001_ $$0P:(DE-Juel1)143792$$aGalldiks, Norbert$$b0$$eCorresponding author
000901792 245__ $$aReply to the letter regarding “Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients—a report of the PET/RANO group”: 18F-fluciclovine and target volume delineation
000901792 260__ $$aOxford$$bOxford Univ. Press$$c2021
000901792 3367_ $$2DRIVER$$aarticle
000901792 3367_ $$2DataCite$$aOutput Types/Journal article
000901792 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1633950955_9853
000901792 3367_ $$2BibTeX$$aARTICLE
000901792 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000901792 3367_ $$00$$2EndNote$$aJournal Article
000901792 536__ $$0G:(DE-HGF)POF4-5253$$a5253 - Neuroimaging (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000901792 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000901792 7001_ $$0P:(DE-HGF)0$$aNiyazi, Maximilian$$b1
000901792 7001_ $$0P:(DE-HGF)0$$aTonn, Jörg-Christian$$b2
000901792 7001_ $$0P:(DE-Juel1)131777$$aLangen, Karl-Josef$$b3
000901792 773__ $$0PERI:(DE-600)2094060-9$$a10.1093/neuonc/noab098$$gVol. 23, no. 8, p. 1410 - 1411$$n8$$p1410 - 1411$$tNeuro-Oncology$$v23$$x1523-5866$$y2021
000901792 8564_ $$uhttps://juser.fz-juelich.de/record/901792/files/noab098.pdf
000901792 909CO $$ooai:juser.fz-juelich.de:901792$$pVDB
000901792 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)143792$$aForschungszentrum Jülich$$b0$$kFZJ
000901792 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131777$$aForschungszentrum Jülich$$b3$$kFZJ
000901792 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5253$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000901792 9141_ $$y2021
000901792 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2021-02-03$$wger
000901792 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-02-03
000901792 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-02-03
000901792 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2021-02-03
000901792 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-02-03
000901792 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-02-03
000901792 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2021-02-03
000901792 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-02-03
000901792 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-02-03
000901792 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEURO-ONCOLOGY : 2019$$d2021-02-03
000901792 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bNEURO-ONCOLOGY : 2019$$d2021-02-03
000901792 9201_ $$0I:(DE-Juel1)INM-4-20090406$$kINM-4$$lPhysik der Medizinischen Bildgebung$$x0
000901792 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x1
000901792 980__ $$ajournal
000901792 980__ $$aVDB
000901792 980__ $$aI:(DE-Juel1)INM-4-20090406
000901792 980__ $$aI:(DE-Juel1)INM-3-20090406
000901792 980__ $$aUNRESTRICTED